Key result
Targeted antihypertensive, lipid-lowering, and antiplatelet therapies significantly reduce cardiovascular events in high-risk patients.
Why the study?
Timely identification and correct management of patients with high and very-high cardiovascular risk can significantly reduce cardiovascular event incidence.
Timely identification and appropriate management with antihypertensive, lipid-lowering, and antiplatelet therapies are essential for reducing cardiovascular events in high-risk patients.
Patients with high and very-high risk of cardiovascular events make up a large group of patients. In this regard, the timely identification of such patients and the correct management can significantly reduce the incidence of cardiovascular events. Potential of antihypertensive, lipid-lowering and antiplatelet therapy are considered.
No takes yet. Share an insight, caveat, or question.
Д. В. Небиеридзе (2021) studied this question. Timely identification and targeted management using antihypertensive, lipid-lowering, and antiplatelet therapies can significantly reduce cardiovascular events in high-risk patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: